BAUDAX BIO
Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.
BAUDAX BIO
Social Links:
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2015-01-01
Address:
Malvern, Pennsylvania, United States
Country:
United States
Website Url:
http://www.baudaxbio.com
Total Employee:
51+
Status:
Active
Contact:
484-395-2440
Email Addresses:
[email protected]
Total Funding:
116.2 M USD
Technology used in webpage:
Amazon U.S. Server Location COVID-19
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Cerevel Therapeutics
Cerevel Therapeutics is a biopharmaceutical company.
Fulgent Therapeutics
Fulgent Therapeutics, LLC is a pharmaceutical company focusing on developing and commercializing innovative cancer therapeutics.
Keros Therapeutics
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.
Mirum Pharmaceuticals
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Provention Bio
Provention Bio is a clinical stage biopharmaceutical dedicated to sourcing, developing and commercializing novel therapeutics.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Rhythm Pharmaceuticals
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2023-06-30 | TeraImmune | TeraImmune acquired by Baudax Bio | N/A |
Investors List
Marathon Asset Management
Marathon Asset Management investment in Post-IPO Debt - Baudax Bio
Official Site Inspections
http://www.baudaxbio.com Semrush global rank: 10.26 M Semrush visits lastest month: 240
- Host name: ec2-54-208-101-55.compute-1.amazonaws.com
- IP address: 54.208.101.55
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Baudax Bio"
Baudax Bio - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 484-395-2440 Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for …See details»
Baudax Bio - LinkedIn
Baudax Bio is a revenue-generating, specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.See details»
Baudax Bio, Inc. - AnnualReports.com
Baudax Bio is a pharmaceutical company focused on therapeutics for acute care settings. The Company’s first commercial product, ANJESO®, had its New …See details»
Baudax Bio, Inc. Company Profile | Malvern, PA | Competitors ...
Find company research, competitor information, contact details & financial data for Baudax Bio, Inc. of Malvern, PA. Get the latest business insights from Dun & Bradstreet.See details»
Baudax Bio Inc (BXRX) Profile - The Globe and Mail
Jan 24, 2003 See the company profile for Baudax Bio Inc (BXRX) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
Baudax Bio, Inc. (BXRXQ) Company Profile & Overview - Stock …
Oct 25, 2024 Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care related settings. The company offers ANJESO …See details»
Baudax Bio Announces Orphan Drug Designation Granted by U.S.
Sep 28, 2023 About Baudax Bio. Baudax Bio is a biotech company focused on innovative products for certain auto-immune conditions, of which many but not all, are orphan drug …See details»
Baudax Bio Company Profile 2024: Valuation, Funding …
Baudax Bio General Information Description. Baudax Bio Inc is a Pharmaceutical company. The company develops and commercialize products for hospital and related acute care settings.See details»
Baudax Bio Announces Corporate Update - Yahoo Finance
Oct 18, 2023 Company Poised to Initiate TI-168 Clinical Development Following Recent Shareholder Approval of Corporate Actions Related to TeraImmune Acquisition Phase 1/2a …See details»
Baudax Bio CEO and Key Executive Team | Craft.co
Baudax Bio's President, Chief Executive Officer is Gerri Henwood. Other executives include William L. Ashton, Director; Winston J. Churchill, Director and 4 others. See the full leadership …See details»
Baudax Bio - Craft
Jul 18, 2024 Baudax Bio has 1 employees at their 1 location and $1.27 m in annual revenue in FY 2022. See insights on Baudax Bio including office locations, competitors, revenue, …See details»
Baudax Bio Acquires TeraImmune, Inc. - Yahoo Finance
Jun 30, 2023 TeraImmune, an Advanced Treg Research Company, headed by Yong Chan Kim, Ph D, brings an approved Treg IND to the Strong Development team from Baudax Baudax Bio …See details»
Baudax Bio Announces Corporate Update - GlobeNewswire
Oct 18, 2023 For more information, please visit www.baudaxbio.com. Forward Looking Statements This press release contains forward-looking statements within the meaning of the …See details»
Baudax Bio™ Launches as a New Pharmaceutical Company Aimed
Nov 21, 2019 For more information please visit www.baudaxbio.com. Cautionary Statement Regarding Forward Looking Statements This press release contains forward-looking …See details»
Baudax Bio Acquires TeraImmune, Inc. - GlobeNewswire
Jun 30, 2023 For more information, please visit www.baudaxbio.com. Forward Looking Statements. This press release contains forward-looking statements that involve risks and …See details»
Baudax Bio Announces $17.6 Million Offering Priced At-the …
Feb 8, 2021 CONTACT: Investor Relations Contact: Argot Partners Sam Martin / Claudia Styslinger (212) 600-1902 [email protected] Baudax Bio, Inc. Ryan D. Lake …See details»
Baudax Bio, Inc. (Baudax Bio, Inc.) - 药物管线_专利_临床试验_投融 …
了解Baudax Bio, Inc. (Baudax Bio, Inc.)公司的药物管线，治疗领域，技术平台，以及它的11项临床试验, 57篇新闻和4篇文献，疾病领域:神经系统疾病，血液及淋巴系统疾病，免疫系统疾 …See details»
Baudax Bio, Inc. (BXRXQ)
Find the latest Baudax Bio, Inc. (BXRXQ) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Baudax Bio Announces Clinical Program Update for - GlobeNewswire
Nov 11, 2021 Baudax Bio Announces Clinical Program Update for Neuromuscular Blocking Agents BX-1000, BX-2000 and BX-3000See details»
Baudax Bio, Inc.'s (BXRX) CEO Gerri Henwood on Q1 2022 Results ...
May 7, 2022 Baudax Bio, Inc. (BXRX) Q1 2022 Earnings Conference Call May 5, 2022 8:30 AM ETCompany ParticipantsSam Martin - Investor RelationsGerri Henwood - President...See details»